All HER2 Positive Breast Cancers Should Get Adjuvant Chemotherapy and Herceptin
From the San Antonio Breast Conference in December, new data shows a higher than predicted rate of breast cancer recurrence even with very small breast cancers that are HER2 positive. The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would... Read more
